Researchers at Rutgers Robert Wood Johnson Medical School have identified immune cells in the intestine that are needed to prevent Inflammatory Bowell Disease (IBD), Colitis and Chron’s disease, which affects three million people in the United States. The Rutgers researchers have been studying the immune response to IBD for the past decade. In a study, published in Science Immunology, researchers said that people with IBD most likely have fewer of these dedicated T cells that are essential for protecting against inflammation in their intestine. Derek Sant’Angelo, associate director of basic science at Robert Wood Johnson Medical School’s Child Health Institute of New Jersey, said prior research indicated that the T cells that controlled the disease were random. This new research, indicating a specific T-cells, provide a better understanding of the basic mechanisms behind the disease and should lead to more meaningful treatment for patients. To read the full story.